Clinical Trial Update: A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating gatifloxacin for safety and efficacy in bacterial conjunctivitis completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• Gatifloxacin (Gatifloxacin)

Snippet

Sponsor: Allergan | Conditions: Bacterial Conjunctivitis | Phase 3 | Status: COMPLETED | Results posted: 2011-11-30